BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36209180)

  • 21. Examination of the best cut-off points of PHQ-2 and GAD-2 for detecting depression and anxiety in Italian cardiovascular inpatients.
    Giuliani M; Gorini A; Barbieri S; Veglia F; Tremoli E
    Psychol Health; 2021 Sep; 36(9):1088-1101. PubMed ID: 33026888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening high-risk patients and assisting in diagnosing anxiety in primary care: the Patient Health Questionnaire evaluated.
    Muntingh AD; De Heer EW; Van Marwijk HW; Adèr HJ; Van Balkom AJ; Spinhoven P; Van der Feltz-Cornelis CM
    BMC Psychiatry; 2013 Jul; 13():192. PubMed ID: 23865984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
    Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
    Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.
    Esser P; Hartung TJ; Friedrich M; Johansen C; Wittchen HU; Faller H; Koch U; Härter M; Keller M; Schulz H; Wegscheider K; Weis J; Mehnert A
    Psychooncology; 2018 Jun; 27(6):1509-1516. PubMed ID: 29473255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutoff of the Zarit Burden Interview in predicting depression and anxiety.
    Yu Y; Liu ZW; Zhou W; Zhao M; Qiu D; Li YL; Xiao SY
    Qual Life Res; 2019 Sep; 28(9):2525-2533. PubMed ID: 31089989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.
    Satre DD; Anderson AN; Leibowitz AS; Levine-Hall T; Slome S; Flamm J; Hare CB; McNeely J; Weisner CM; Horberg MA; Volberding P; Silverberg MJ
    Contemp Clin Trials; 2019 Sep; 84():105833. PubMed ID: 31446142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for depression in acute coronary syndrome patients: A comparison of Patient Health Questionnaire-9 versus Hospital Anxiety and Depression Scale-Depression.
    Yuan J; Ding R; Wang L; Sheng L; Li J; Hu D
    J Psychosom Res; 2019 Jun; 121():24-28. PubMed ID: 30928210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease.
    Stafford L; Berk M; Jackson HJ
    Gen Hosp Psychiatry; 2007; 29(5):417-24. PubMed ID: 17888808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update of the standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
    Wicke FS; Krakau L; Löwe B; Beutel ME; Brähler E
    J Affect Disord; 2022 Sep; 312():310-314. PubMed ID: 35760191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the utility of the PHQ and CES-D for depression screening among youth with HIV in an integrated care setting.
    Chenneville T; Gabbidon K; Drake H; Rodriguez C
    J Affect Disord; 2019 May; 250():140-144. PubMed ID: 30852366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Validity and Reliability of the PHQ-9 and PHQ-2 on Screening for Major Depression in Spanish Speaking Immigrants in Chile: A Cross-Sectional Study.
    Errazuriz A; Beltrán R; Torres R; Passi-Solar A
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Psychometric Properties of the Patient Health Questionnaire-4 for Pregnant Women.
    Rodríguez-Muñoz MF; Ruiz-Segovia N; Soto-Balbuena C; Le HN; Olivares-Crespo ME; Izquierdo-Méndez N
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33086483
    [No Abstract]   [Full Text] [Related]  

  • 33. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review.
    Kroenke K; Spitzer RL; Williams JB; Löwe B
    Gen Hosp Psychiatry; 2010; 32(4):345-59. PubMed ID: 20633738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa.
    Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska JA
    AIDS Behav; 2014 Jun; 18(6):1133-41. PubMed ID: 24452497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validity of brief screening questionnaires to detect depression in primary care in Ethiopia.
    Hanlon C; Medhin G; Selamu M; Breuer E; Worku B; Hailemariam M; Lund C; Prince M; Fekadu A
    J Affect Disord; 2015 Nov; 186():32-9. PubMed ID: 26226431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for depression in pregnant women from Côte d׳Ivoire and Ghana: Psychometric properties of the Patient Health Questionnaire-9.
    Barthel D; Barkmann C; Ehrhardt S; Schoppen S; Bindt C;
    J Affect Disord; 2015 Nov; 187():232-40. PubMed ID: 26343851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening male prisoners for depression and anxiety with the PHQ-9 and GAD-7 at NHS Healthcheck: patterns of symptoms and caseness threshold.
    Butcher E; Packham C; Williams M; Miksza J; Kaul A; Khunti K; Morriss R
    BMC Psychiatry; 2021 Sep; 21(1):446. PubMed ID: 34496806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric Validation of a Combined Assessment for Anxiety and Depression in Primary Care in Mozambique (CAD-MZ).
    Belus JM; Muanido A; Cumbe VFJ; Manaca MN; Wagenaar BH
    Assessment; 2022 Dec; 29(8):1890-1900. PubMed ID: 34353141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic.
    Valentine A; Brown J; Lacourt T; Chen M; De La Garza R; Bruera E
    Psychooncology; 2022 Feb; 31(2):290-297. PubMed ID: 34546618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of patient health questionnaire (PHQ) for major depression in Chinese outpatients with multiple somatic symptoms: a multicenter cross-sectional study.
    Xiong N; Fritzsche K; Wei J; Hong X; Leonhart R; Zhao X; Zhang L; Zhu L; Tian G; Nolte S; Fischer F
    J Affect Disord; 2015 Mar; 174():636-43. PubMed ID: 25576931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.